COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804


Print ISSN:-2394-4781

Online ISSN:-2394-4994

CODEN : IJCACT

Current Issue

Year 2020

Volume: 7 , Issue: 2

Article Access statistics

Viewed: 694

Emailed: 0

PDF Downloaded: 214

Indian Journal of Clinical Anaesthesia


Role of IV Nalbuphine in attenuation of haemodynamic response to laryngoscopy and endotracheal intubation


Full Text PDF Share on Facebook Share on Twitter


Author Details : Dnyaneshwar Ramaji Fating, Ashwini K. Dandekar, N.G. Tirpude

Volume : 3, Issue : 2, Year : 2016

Article Page : 165-169


Suggest article by email

Abstract

Background: Laryngoscopy and endotracheal intubation evoke a haemodynamic response leading to increased heart rate and blood pressure. Purpose of present study was to evaluate the efficacy of Nalbuphine for attenuation of haemodynamic response to laryngoscopy and intubation.
Methods: 120 patients belonging to ASA Grade I and II, posted for elective laparoscopic surgery under general anaesthesia were included in this double blind prospective randomised study. Patients were randomly allocated in two groups to receive either injection Nalbuphine IV 0.2mg/kg diluted to 5 ml with normal saline (Group N) or 5 ml normal saline (Group C), five minutes before induction. Monitoring of heart rate, systolic blood pressure, diastolic blood pressure and mean arterial blood pressure was done at laryngoscopy and endotracheal intubation and 1, 3, 5, 7 and 10 minutes after laryngoscopy and endotracheal intubation.
Results: Increase in heart rate, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure in Group N was lower than in Group C.
Conclusion: Intravenous Nalbuphine in the dose of 0.2 mg/kg appears to be a promising drug which can be used to attenuate the haemodynamic response to laryngoscopy and intubation.

Keywords:
Nalbuphine, Haemodynamic response, Laryngoscopy, Intubation, Heart Rate and Mean arterial blood pressure

How to cite : Fating D R, Dandekar A K, Tirpude N, Role of IV Nalbuphine in attenuation of haemodynamic response to laryngoscopy and endotracheal intubation. Indian J Clin Anaesth 2016;3(2):165-169

Copyright © 2016 by author(s) and Indian J Clin Anaesth. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)